Circio Holding ASA (OSL:CRNA) Debt-to-Equity : -1.15 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA Debt-to-Equity?

Circio Holding ASA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr110.65 Mil. Circio Holding ASA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.00 Mil. Circio Holding ASA's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr-96.34 Mil. Circio Holding ASA's debt to equity for the quarter that ended in Dec. 2023 was -1.15.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Circio Holding ASA's Debt-to-Equity or its related term are showing as below:

OSL:CRNA' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.15 Med: 0.14 Max: 24.72
Current: -1.15

During the past 12 years, the highest Debt-to-Equity Ratio of Circio Holding ASA was 24.72. The lowest was -1.15. And the median was 0.14.

OSL:CRNA's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.15 vs OSL:CRNA: -1.15

Circio Holding ASA Debt-to-Equity Historical Data

The historical data trend for Circio Holding ASA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Debt-to-Equity Chart

Circio Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.18

0.17

0.14

24.72

-1.15

Circio Holding ASA Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.16	0.17	24.72	-1.37	-1.15

Competitive Comparison of Circio Holding ASA's Debt-to-Equity

For the Biotechnology subindustry, Circio Holding ASA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Circio Holding ASA's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Debt-to-Equity falls into.

Circio Holding ASA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Circio Holding ASA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(110.653	+	0)	/	-96.337
	=	-1.15

Circio Holding ASA's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(110.653	+	0)	/	-96.337
	=	-1.15

Circio Holding ASA (OSL:CRNA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Circio Holding ASA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Circio Holding ASA (OSL:CRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

TA50:Germany

Address

Vollsveien 19, Lysaker, Oslo, NOR, 1366

Website

https://www.circio.com

Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (OSL:CRNA) Headlines

No Headlines